UMIN-CTR History

Name：　　UMIN ID：

Unique ID issued by UMIN	UMIN000003215
Receipt number	R000003807
Scientific Title	A Phase II Study for the efficacy and safety of Erlotinib for Patients previously treated Non-small cell Lung Cancer Patients with EGFR Mutations
Date of disclosure of the study information	2010/02/20
Last modified on	2010/02/19 20:22:20

---